The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus
Authors:
- Ewa RzeszotarskaEREwa Rzeszotarska
- Anna SowinskaASAnna Sowinska
- Barbara StypinskaBSBarbara Stypinska
- Ewa WalczukEWEwa Walczuk
- Anna WajdaAWAnna Wajda
- Anna LutkowskaALAnna Lutkowska
- Anna Felis-GiemzaAFAnna Felis-Giemza
- Marzena OlesinskaMarzena Olesinska
- Mariusz PuszczewiczMPMariusz Puszczewicz
- Dominik MajewskiDMDominik Majewski
- Pawel Piotr JagodzinskiPJPawel Piotr Jagodzinski
- Michal CzerewatyMCMichal Czerewaty
Open Access
- 24 March 2020
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 10 (3) , 494
Abstract
Systemic lupus erythematosus (SLE) is a chronic and systemic autoimmune disease. SLE is described by production of autoantibodies and causes damage of many organs. T-cells play a crucial role in SLE pathogenesis. T-cells intensify inflammation through a number of processes, which leads to autoimmunization. CCR5 and MECP2 genes are linked with T-cells and pathogenesis of SLE. Polymorphisms in these genes are related with the prognostic factors of risk of disease onset and disease severity. The aim of this study was to estimate the influence of polymorphisms in MECP2 and CCR5 genes on the development and course of systemic lupus erythematosus. We examined 137 SLE patients and 604 healthy controls. We studied polymorphisms for CCR5 gene: rs333 and for MECP2: rs2075596, rs1734787, rs17435, and rs2239464. We genotyped our MECP2 samples and we performed a restriction fragment length polymorphism (RFLP) analysis for CCR5 samples. We showed a risk factor for allele T in rs17435 and for allele A in rs2075596 in MECP2. We noticed that MECP2 rs2075596 G/A, rs1734787 C/A, rs17435 A/T, and rs2239464 G/A polymorphisms are more prevalent in SLE patients than in healthy controls. We believe that above-mentioned MECP2 polymorphisms can be considered as SLE susceptibility factor.Keywords
This publication has 46 references indexed in Scilit:
- Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groupsAnnals of the Rheumatic Diseases, 2013
- Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2011
- MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and FibrosisGastroenterology, 2010
- A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populationsProceedings of the National Academy of Sciences, 2009
- Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritisArthritis Research & Therapy, 2009
- Replication of recently identified systemic lupus erythematosus genetic associations: a case–control studyArthritis Research & Therapy, 2009
- Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosusArthritis & Rheumatism, 2009
- Common Variants within MECP2 Confer Risk of Systemic Lupus ErythematosusPLOS ONE, 2008
- Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritisBMC Medical Genetics, 2007
- Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2005